Beijing Leadman Biochemistry Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 340.14 million compared to CNY 541.96 million a year ago. Revenue was CNY 340.14 million compared to CNY 541.96 million a year ago.

Net income was CNY 23.77 million compared to CNY 34.47 million a year ago. Basic earnings per share from continuing operations was CNY 0.0437 compared to CNY 0.0634 a year ago. Diluted earnings per share from continuing operations was CNY 0.0437 compared to CNY 0.0634 a year ago.